{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:20Z","timestamp":1759047860482},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.lpm.2009.06.022","type":"journal-article","created":{"date-parts":[[2010,2,9]],"date-time":"2010-02-09T10:13:08Z","timestamp":1265710388000},"page":"371-380","source":"Crossref","is-referenced-by-count":7,"title":["Neuro-optico-my\u00e9lite aigu\u00eb de Devic et les syndromes neurologiques apparent\u00e9s"],"prefix":"10.1016","volume":"39","author":[{"given":"Romain","family":"Marignier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Confavreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.06.022_bib1","first-page":"1033","article-title":"Myelite subaigu\u00eb compliqu\u00e9e de n\u00e9vrite optique","volume":"8","author":"Devic","year":"1894","journal-title":"Bull Med"},{"key":"10.1016\/j.lpm.2009.06.022_bib2","unstructured":"Gault F. De la neuromy\u00e9lite optique aigu\u00eb. (th\u00e8se no\u00a0891). Facult\u00e9 de M\u00e9decine et de Pharmacie de Lyon;1894."},{"key":"10.1016\/j.lpm.2009.06.022_bib3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib4","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/brain\/awf151","article-title":"A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica","volume":"125","author":"Lucchinetti","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/1352458503ms947oa","article-title":"Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis","volume":"9","author":"De S\u00e8ze","year":"2003","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib6","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib7","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2009.06.022_bib8","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/jnnp.57.9.1140","article-title":"MRI of neuromyelitis optica: evidence for a distinct entity","volume":"57","author":"Fazekas","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.06.022_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.42.1.250","article-title":"Long-term follow-up of acute partial transverse myelopathy","volume":"42","author":"Ford","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib10","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458504ms988oa","article-title":"Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations","volume":"10","author":"Bergamaschi","year":"2004","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/archneurol.2007.17","article-title":"Neuromyelitis optica and non organ-specific autoimmunity","volume":"65","author":"Pittock","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib12","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","article-title":"Revised diagnostic criteria for neuromyelitis optica","volume":"66","author":"Wingerchuk","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.60.4.382","article-title":"Clinical, CSF, and MRI findings in Devic's neuromyelitis optica","volume":"60","author":"O\u2019Riordan","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.06.022_bib14","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0022-510X(02)00043-6","article-title":"Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile","volume":"197","author":"De Seze","year":"2002","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2009.06.022_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00415-004-0271-0","article-title":"Italian Devic's Study Group (IDESG). Clnical characteristics course and prognosis of relapsing Devic's neuromyelitis optica","volume":"251","author":"Ghezzi","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib16","unstructured":"Collongues N, Marignier R, Zephir H, Papeix C, Blanc F, Ritleng et al. Neuromyelitis optica in France: a multicentric study of 125 patients."},{"key":"10.1016\/j.lpm.2009.06.022_bib17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","article-title":"Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders","volume":"70","author":"Banwell","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib18","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1093\/brain\/awm224","article-title":"Does mitochondrial DNA predispose to neuromyelitis optica (Devic's disease)?","volume":"131","author":"Hudson","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib19","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/brain\/122.9.1689","article-title":"HLA-DPB1*0501-associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies","volume":"122","author":"Yamasaki","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1352458508102085","article-title":"Is neuromyelitis optica associated with human leukocyte antigen?","volume":"15","author":"Z\u00e9phir","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1212\/01.wnl.0000254502.87233.9a","article-title":"A secondary progressive clinical course is uncommon in neuromyelitis optica","volume":"68","author":"Wingerchuk","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib22","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00415-006-0116-0","article-title":"A patient with a benign course of neuromyelitis optica (Devic's syndrome) over 12\u00a0years: MRI follow up and histological findings","volume":"253","author":"K\u00f6ller","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib23","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1212\/01.WNL.0000049912.02954.2C","article-title":"Neuromyelitis optica: clinical predictors of a relapsing course and survival","volume":"60","author":"Wingerchuk","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib24","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4\u00a0immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1084\/jem.20050304","article-title":"IgG marker of optic-spinal multiple sclerosis bind to the aquaporin 4\u00a0water channel","volume":"202","author":"Lennon","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2009.06.022_bib26","first-page":"314","article-title":"NMO-IgG antibodies in neuromyelitis optica: a report of 2\u00a0cases","volume":"21","author":"Zuliani","year":"2006","journal-title":"Neurologia"},{"key":"10.1016\/j.lpm.2009.06.022_bib27","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1212\/01.wnl.0000256822.01222.bd","article-title":"NMO-IgG in the diagnosis of neuromyelitis optica","volume":"68","author":"Jarius","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib28","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1352458507084595","article-title":"NMO-IgG and Devic's neuromyelitis optica: a French experience","volume":"14","author":"Marignier","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib29","first-page":"S290","article-title":"Evaluation of different techniques to detect anti-aquaporin 4\u00a0antibodies in neuromyelitis optica patients","volume":"14","author":"Fazio","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/brain\/awm062","article-title":"Anti-aquaporin-4\u00a0antibody is involved in the pathogenesis of NMO: a study on antibody titre","volume":"130","author":"Takahashi","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1177\/1352458507076976","article-title":"Anti-aquaporin 4\u00a0antibody in selected Japanese multiple sclerosis patients with long spinal cord lesions","volume":"13","author":"Tanaka","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4\u00a0antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib33","first-page":"99","article-title":"Detection of anti-aquaporin-4\u00a0antibodies in neuromyelitis optica: current status of the assays","volume":"15","author":"Waters","year":"2008","journal-title":"Int MS J"},{"key":"10.1016\/j.lpm.2009.06.022_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"12","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.lpm.2009.06.022_bib35","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/archneur.63.3.390","article-title":"Brain abnormalities in neuromyelitis optica","volume":"63","author":"Pittock","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00415-008-0545-z","article-title":"Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study","volume":"255","author":"Nakamura","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib37","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neurad.2008.12.008","article-title":"MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis","volume":"36","author":"Cassinotto","year":"2009","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.lpm.2009.06.022_bib38","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.209.269","article-title":"Loss of aquaporin-4\u00a0in active perivascular lesions in neuromyelitis optica: a case report","volume":"209","author":"Misu","year":"2006","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.lpm.2009.06.022_bib39","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib40","doi-asserted-by":"crossref","first-page":"5730","DOI":"10.4049\/jimmunol.181.8.5730","article-title":"Functional consequences of neuromyelitis optica-IgG astrocyte interactions on blood-brain barrier permeability and granulocyte recruitment","volume":"181","author":"Vincent","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.lpm.2009.06.022_bib41","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2009.06.022_bib42","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ana.20770","article-title":"Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis","volume":"59","author":"Weinshenker","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib43","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","article-title":"NMO-IgG predicts the outcome of recurrent optic neuritis","volume":"70","author":"Matiello","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib44","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1212\/01.wnl.0000313375.20123.25","article-title":"Relapsing inflammatory optic neuritis: is it neuromyelitis optica?","volume":"70","author":"De S\u00e8ze","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib45","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1136\/jnnp.2007.135228","article-title":"Hypocretinergic dysfunction in neuromyelitis optica with coma-like episodes","volume":"79","author":"Carlander","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.06.022_bib46","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1136\/jnnp.2008.145391","article-title":"Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4\u00a0antibody: a herald of acute exacerbations","volume":"79","author":"Takahashi","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.06.022_bib47","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Maga\u00f1a","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000314832.24682.c6","article-title":"CNS aquaporin-4\u00a0autoimmunity in children","volume":"71","author":"McKeon","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib49","article-title":"Recurrent neuromyelitis optica in Brazilian patients : clinical, immunological, and neuroimaging characteristics","author":"Adoni","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib50","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1177\/1352458508092811","article-title":"Neuromyelitis optica immunoglobulins as a marker of disease activity and response to therapy in patients with neuromyelitis optica","volume":"14","author":"Weinstock-Guttman","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib51","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4\u00a0in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2009.06.022_bib52","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","article-title":"A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease","volume":"46","author":"Weinshenker","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib54","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/1352458506071174","article-title":"Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica","volume":"13","author":"Watanabe","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1017\/S0317167100053932","article-title":"Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG)","volume":"31","author":"Bakker","year":"2004","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.lpm.2009.06.022_bib56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.2005.086306","article-title":"Fulminant Devic disease successfully treated by lymphocytapheresis","volume":"77","author":"Nozaki","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2009.06.022_bib57","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1212\/WNL.51.4.1219","article-title":"Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine","volume":"51","author":"Mandler","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib58","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archneur.63.7.957","article-title":"Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease)","volume":"63","author":"Weinstock-Guttman","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1177\/1352458506070732","article-title":"Immunosuppressive therapy is more effective than interferon in neuromyelitis optica","volume":"13","author":"Papeix","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.lpm.2009.06.022_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jns.2006.10.008","article-title":"Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination","volume":"252","author":"Warabi","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2009.06.022_bib61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0901","article-title":"B cells as therapeutic targets in autoimmune neurological disorders","volume":"4","author":"Dalakas","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib62","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/01.WNL.0000159399.81861.D5","article-title":"An open label study of the effects of rituximab in neuromyelitis optica","volume":"64","author":"Cree","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2009.06.022_bib63","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1001\/archneur.65.11.noc80069","article-title":"Treatment of Neuromyelitis optica with rituximab: Retrospective Analysis of 25\u00a0Patients","volume":"65","author":"Jacob","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2009.06.022_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10072-007-0823-z","article-title":"Variable responses to rituximab treatment in neuromyelitis optica (Devic's disease)","volume":"28","author":"Capobianco","year":"2007","journal-title":"Neurol Sci."},{"key":"10.1016\/j.lpm.2009.06.022_bib65","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/sc.2008.99","article-title":"Isolated longitudinal myelitis: a report of six cases","volume":"47","author":"Pawate","year":"2009","journal-title":"Spinal Cord."},{"key":"10.1016\/j.lpm.2009.06.022_bib66","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10067-008-0936-7","article-title":"A case of longitudinally extensive transverse myelitis (LETM): neuromyelitis optica","volume":"27","author":"Mangat","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.lpm.2009.06.022_bib67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.neurol.2007.10.009","article-title":"Failure of rituximab in relapsing neuromyelitis optica: case report with two-year prospective follow-up","volume":"164","author":"Cassinotto","year":"2008","journal-title":"Rev Neurol (Paris)"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209005612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498209005612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,13]],"date-time":"2018-12-13T05:23:58Z","timestamp":1544678638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498209005612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0755498209005612"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.06.022","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}